Frontlight ResearchEarly access
CompletedNo phase
MRI & QST Analysis in Trigeminal Neuralgia and Persistent Idiopathic Facial Pain
Key facts
- Who runs it
- Walton Centre NHS Foundation Trust
- Where
- United Kingdom1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 40 people enrolled
- Started
- 11 Nov 2021
- Ended
- 20 Nov 2024
- Type of study
- Observational, 2 groups
- Treatments tested
- Quantitative Sensory Testing
- Record updated
- 8 September 2026
Who can take part
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 6 criteriaShow less
Who can take part
- Definite diagnosis of Classical or Idiopathic Trigeminal Neuralgia or Persistent Idiopathic Facial Pain according to the latest ICOP 2020 Criteria
- Naive to any surgical procedures
Who cannot take part
- Any major chronic painful or other neurological disease
- Diagnosis of other facial pain syndromes
- Diagnosis of Secondary Trigeminal Neuralgia
- Cognitive disturbances
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
Patients with a definite diagnosis of classical TGN and PIFP will undergo a structured clinical questionnaire and a trigeminal sensory profile using the quantitative sensory testing. Clinical measures and sensory profiles will be correlated with MRI measures.
The 2 groups in the trial
- Trigeminal Neuralgia
Patients with a definite diagnosis of Classical or Idiopathic Trigeminal Neuralgia
Treatment: Quantitative Sensory Testing
- Persistent Idiopathic Facial Pain
Patients with a definite diagnosis of Persistent Idiopathic Facial Pain
Treatment: Quantitative Sensory Testing
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Assessing Somatosensory System Damage in Trigeminal Neuralgia and Persistent Idiopathic Facial Pain Through Neuroimaging and Quantitative Sensory Testing
- Record updated
- 8 September 2026